
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 07, 2023, titled "Media release: Q3 of 2022-23".
Filed with NSE ·

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 07, 2023, titled "Media release: Q3 of 2022-23".
6ix hasn’t read this filing yet.
GlaxoSmithKline Pharmaceuticals Limited on 6ix
Follow GlaxoSmithKline Pharmaceuticals into a list and get an email when it puts out news.
Follow GlaxoSmithKline Pharmaceuticals